1. 1473PImmune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients. (23rd October 2018) Authors: Kubo, T; Watanabe, H; Ninomiya, K; Kudo, K; Minami, D; Murakami, E; Ochi, N; Ninomiya, T; Harada, D; Yasugi, M; Ichihara, E; Ohashi, K; Fujiwara, K; Hotta, K; Tabata, M; Maeda, Y; Kiura, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 464OInduction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study. (24th November 2019) Authors: Saeki, S; Hotta, K; Yamaguchi, M; Harada, D; Bessho, A; Tanaka, K; Inoue, K; Gemba, K; Inoue, K; Ichihara, E; Kishimoto, J; Sasaki, T; Shioyama, Y; Katsui, K; Sasaki, J; Kiura, K; Sugio, K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood group antigens A, B, H, Lea, Leb, and I(Ma) in resting and tetragastrin stimulated gastric juice of patients with non-neoplastic diseases of the stomach. Issue 3 (March 1985) Authors: Picard, J K; Hotta, K; Feizi, T Journal: Journal of clinical pathology Issue: Volume 38:Issue 3(1985) Page Start: 320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Issue 6 (June 1980) Authors: Azuumi, Y; Ohara, S; Ishihara, K; Okabe, H; Hotta, K Journal: Gut Issue: Volume 21:Issue 6(1980) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gastrointestinal: Transurethral endoscopic retrograde pancreatography. Issue 11 (10th October 2017) Authors: Kawakubo, K; Kuwatani, M; Shimamura, T; Yamashita, K; Goto, R; Watanabe, M; Koshizuka, Y; Kawamura, N; Iwami, D; Hotta, K; Sano, I; Sugiura, R; Kato, S; Shinohara, N; Taketomi, A; Sakamoto, N Journal: Journal of gastroenterology and hepatology Issue: Volume 32:Issue 11(2017) Page Start: 1791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LBA15Overall survival with first-line durvalumab plus platinum-etoposide in patients with extensive-stage (ES)-SCLC in CASPIAN: Subgroup findings from Asia. (24th November 2019) Authors: Nishio, M; Ji, J H; Hotta, K; Chiu, C-H; Lee, J-S; Azuma, K; Kim, S-W; Wu, S-Y; Dvorkin, M; Trukhin, D; Havel, L; Hochmair, M J; Özgüroğlu, M; Bar, J; Chen, Y; Goldman, J W; Byrne, N; Laud, P J; Shire, N; Paz-Ares, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LBA2 First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC: Safety, pharmacokinetics (PK) and immunogenicity in CASPIAN. (15th December 2019) Authors: Özgüroğlu, M; Goldman, J W; Reinmuth, N; Chen, Y; Dvorkin, M; Trukhin, D; Statsenko, G; Hotta, K; Ji, J H; Hochmair, M J; Voitko, O; Havel, L; Poltoratskiy, A; Losonczy, G; Verderame, F; Thomas, M; Zheng, Y; Lloyd, A; Jiang, H; Paz-Ares, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗